The company's new offering Health Panels will allow members to schedule and view lab test results in the Oura App.

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

Health Informatics is the application of information technology to healthcare. It's the foundation of Digital Health, ...

Oura Health makes a pricey smart ring that busy executives, celebrities and others use to track health measures like their ...

Bluevine reports that 78.9% of aspiring entrepreneurs believe now is a good time to start a business, despite economic ...

The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that ...

BMO senior economist Sal Guatieri points out the severe negative effects of the trade war on industrial investment, ...

Wall Street closed higher Friday, marking its third straight weekly gain, after the Federal Reserve delivered a long-awaited 25 basis-point rate cut—the first in nine months. The Fed’s updated ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...

Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...